QQQ   425.79 (-1.23%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   425.79 (-1.23%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   425.79 (-1.23%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   425.79 (-1.23%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

HealthEquity (HQY) Stock Price, News & Analysis

$80.09
-0.18 (-0.22%)
(As of 12:46 PM ET)
Today's Range
$80.07
$81.86
50-Day Range
$77.39
$83.53
52-Week Range
$48.86
$84.49
Volume
120,812 shs
Average Volume
602,066 shs
Market Capitalization
$6.87 billion
P/E Ratio
125.14
Dividend Yield
N/A
Price Target
$96.17

HealthEquity MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
20.1% Upside
$96.17 Price Target
Short Interest
Healthy
3.47% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.82mentions of HealthEquity in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$5.68 M Sold Last Quarter
Proj. Earnings Growth
31.60%
From $2.12 to $2.79 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.12 out of 5 stars

Medical Sector

154th out of 913 stocks

Business Services, Not Elsewhere Classified Industry

26th out of 89 stocks

HQY stock logo

About HealthEquity Stock (NASDAQ:HQY)

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

HQY Stock Price History

HQY Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
HQY Quantitative Stock Analysis
HealthEquity (NASDAQ:HQY) Stock Price Up 2.6%
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Jefferies Keeps Their Buy Rating on Healthequity (HQY)
Barclays Keeps Their Buy Rating on Healthequity (HQY)
Recap: HealthEquity Q4 Earnings
Here's what to expect from HealthEquity's earnings report
HealthEquity Q4 2024 Earnings Preview
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/19/2024
Today
4/17/2024
Next Earnings (Estimated)
6/03/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:HQY
Employees
3,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$96.17
High Stock Price Target
$110.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+19.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$55.71 million
Pretax Margin
7.51%

Debt

Sales & Book Value

Annual Sales
$999.59 million
Cash Flow
$3.44 per share
Book Value
$23.72 per share

Miscellaneous

Free Float
83,483,000
Market Cap
$6.89 billion
Optionable
Optionable
Beta
0.53
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

HQY Stock Analysis - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price target for 2024?

11 equities research analysts have issued 12-month price objectives for HealthEquity's shares. Their HQY share price targets range from $72.00 to $110.00. On average, they predict the company's stock price to reach $96.17 in the next twelve months. This suggests a possible upside of 20.1% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2024?

HealthEquity's stock was trading at $66.30 on January 1st, 2024. Since then, HQY shares have increased by 20.8% and is now trading at $80.09.
View the best growth stocks for 2024 here
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024.
View our HQY earnings forecast
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings data on Tuesday, March, 19th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. The business earned $262.39 million during the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a trailing twelve-month return on equity of 6.91%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2025 earnings guidance on Thursday, April, 11th. The company provided EPS guidance of 2.790-2.960 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by many different institutional and retail investors. Top institutional investors include Inspirion Wealth Advisors LLC (0.09%), Los Angeles Capital Management LLC (0.04%), BTC Capital Management Inc. (0.01%) and Rise Advisors LLC (0.00%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Evelyn S Dilsaver, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HQY) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners